Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex... see more

Recent & Breaking News (OTCPK:AZNCF)

Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations

PR Newswire October 22, 2015

How Young is Your Heart?

PR Newswire October 14, 2015

AstraZeneca Presents Respiratory Syncytial Virus (RSV) Study Results at IDWeek 2015

Business Wire October 8, 2015

SYMBICORT Real-World Study Results Published in the International Journal of COPD

Business Wire September 30, 2015

New Dose of Brilinta Now Available in US Pharmacies

Business Wire September 29, 2015

The National Forum for Heart Disease & Stroke Prevention and AstraZeneca Ask You to Join in Raising Awareness of Cholesterol Health with World Heart Day Thunderclap

PR Newswire September 25, 2015

AstraZeneca to Present Data Demonstrating Diversity of Its Portfolio of Innovative Formulations and Devices at the European Respiratory Society International Congress 2015

Business Wire September 22, 2015

Allergan Anti-Infective Portfolio Highlighted in 24 Abstracts at ICAAC 2015

PR Newswire September 16, 2015

AstraZeneca Purchases US Biologics Manufacturing Facility to Support Growing Pipeline

Business Wire September 11, 2015

AstraZeneca to Update on Leading Lung Cancer Portfolio at WCLC 2015

Business Wire September 4, 2015

US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack

PR Newswire September 3, 2015

Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)

PR Newswire September 2, 2015

AstraZeneca and Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial

GlobeNewswire August 24, 2015

Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement

Business Wire July 30, 2015

Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City

PR Newswire July 14, 2015

IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Business Wire July 13, 2015

AstraZeneca Celebrates More Than 35 Years of Ongoing Patient Support Through Its Patient Assistance Programs

Business Wire July 8, 2015

Lions Health Announces Winners

ACN Newswire June 21, 2015

AstraZeneca Announces Phase III Results for Lesinurad in Combination with Febuxostat in Tophaceous Gout Patients at European League Against Rheumatism Annual Congress (EULAR 2015)

Business Wire June 13, 2015

Cholesterol Awareness Initiative Makes Its Move Across America

PR Newswire June 8, 2015